Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 812

Showing 1-25 of 812 citing articles:

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Naga Chalasani, Manal F. Abdelmalek, Guadalupe García‐Tsao, et al.
Gastroenterology (2019) Vol. 158, Iss. 5, pp. 1334-1345.e5
Open Access | Times Cited: 259
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Leen Heyens, Dana Busschots, Ger H. Koek, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 156
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
Zui Tan, Hongbao Sun, Taixiong Xue, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 150
Oxidative Stress in Liver Pathophysiology and Disease
Abdolamir Allameh, Reyhaneh Niayesh‐Mehr, Azadeh Aliarab, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1653-1653
Open Access | Times Cited: 101
Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 73
Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 44
Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
Liang Shan, Fengling Wang, Dandan Zhai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114472-114472
Open Access | Times Cited: 36
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Raquel Benedé‐Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 30
Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease
Sophie Gensluckner, Bernhard Wernly, Christian Datz, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 208-208
Open Access | Times Cited: 16
Oxytocin alleviates liver fibrosis via hepatic macrophages
Xiangyu Zhai, Hao Zhang, Zhijia Xia, et al.
JHEP Reports (2024) Vol. 6, Iss. 6, pp. 101032-101032
Open Access | Times Cited: 13
Statins: Old drugs as new therapy for liver diseases?
Elisa Pose, Jonel Trebicka, Rajeshwar P. Mookerjee, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 1, pp. 194-202
Open Access | Times Cited: 139
STAT3: A key regulator in liver fibrosis
Jie Zhao, Yongfen Qi, Yan-Rong Yu
Annals of Hepatology (2020) Vol. 21, pp. 100224-100224
Open Access | Times Cited: 119
Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid
Sumio Hayakawa, Tomokazu Ohishi, Noriyuki Miyoshi, et al.
Molecules (2020) Vol. 25, Iss. 19, pp. 4553-4553
Open Access | Times Cited: 117
Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer
Isabella Lurje, Linda Hammerich, Frank Tacke
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7378-7378
Open Access | Times Cited: 84
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
Zhongyi Wang, Adrian Keogh, Annick Waldt, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 74
Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis
Divya Jain, Priya Chaudhary, Nidhi Varshney, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 66
Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
Yifei Wang, Bin Huang, Tao Jin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 60
Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yufei Yan, Jiefei Zeng, Linhao Xing, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1014-1014
Open Access | Times Cited: 55
Rebalancing TGF‐β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis
Yang Yang, Mayu Sun, Weida Li, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 55
Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling
Chenxu Ge, Jun Tan, Deshuai Lou, et al.
Redox Biology (2022) Vol. 51, pp. 102274-102274
Open Access | Times Cited: 52
Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1/P53/SLC7A11 pathway
Guofang Liu, Can Wei, Siyu Yuan, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 11, pp. 4230-4243
Closed Access | Times Cited: 52
Stem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential
Pinyan Liu, Yongcui Mao, Ye Xie, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
New Drugs for Hepatic Fibrosis
Liang Shan, Fengling Wang, Dandan Zhai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
Marawan A. Elbaset, Rana S. Salem, Fairouz Ayman, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2152-2152
Open Access | Times Cited: 42
Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation
Lihua Li, Kunpeng Wang, Rongjun Jia, et al.
Redox Biology (2022) Vol. 56, pp. 102435-102435
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top